Chinese Journal of Respiratory and Critical Care Medicine
Supervisor：Ministry of Education of the People's Republic of ChinaSponsor：West China Medical Center & West China Hospital, Sichuan University Editor-in-chief：LIN Jiangtao / LIU Chuntao Publishing period：
Monthly
ISSN：1671-6205CN：51-1631/R
Citation：唐晉, 肖軍. 肺動靜脈畸形一例. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(5): 505-506. doi: 10.7507/1671-6205.201902037Copy
Copyright ? the editorial department of Chinese Journal of Respiratory and Critical Care Medicine of West China Medical Publisher. All rights reserved
1.
Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med, 2012, 51(13): 1677-1681.
2.
Faughnan ME, Palda VA, Garcia-Tsao G, et al. HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 2011, 48: 73-87.
3.
Shovlin CL, Guttmacher E, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000, 91: 66-67.
4.
Hsu CC, Kwan GN, Thompson SA. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev, 2012, 8: CD008017.
5.
Howard LS, Santhirapala V, Murphy K, et al. Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations. Chest, 2014, 146: 709-718.
6.
Finnamore H, Le Couteur J, Hickson M, et al. Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS ONE, 2013, 8: e76516.
7.
Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med, 2014, 190: 1217-1228.
1. Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med, 2012, 51(13): 1677-1681.
2. Faughnan ME, Palda VA, Garcia-Tsao G, et al. HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 2011, 48: 73-87.
3. Shovlin CL, Guttmacher E, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000, 91: 66-67.
4. Hsu CC, Kwan GN, Thompson SA. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev, 2012, 8: CD008017.
5. Howard LS, Santhirapala V, Murphy K, et al. Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations. Chest, 2014, 146: 709-718.
6. Finnamore H, Le Couteur J, Hickson M, et al. Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS ONE, 2013, 8: e76516.
7. Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med, 2014, 190: 1217-1228.
1/5
WeChat